A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Pardes Biosciences, Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 5,227,307 shares of PRDS stock, worth $0. This represents 29.04% of its overall portfolio holdings.

Number of Shares
5,227,307
Previous 5,227,307 -0.0%
Holding current value
$0
Previous $16 Million 39.74%
% of portfolio
29.04%
Previous 40.44%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$9.8 - $17.02 $51.2 Million - $89 Million
5,227,307 New
5,227,307 $85.6 Million

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0

About PARDES BIOSCIENCES, INC.


  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Foresite Capital Opportunity Management V, LLC Portfolio

Follow Foresite Capital Opportunity Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Opportunity Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Opportunity Management V, LLC with notifications on news.